Core Insights - Medicare open enrollment for 2026 is approaching, with significant changes expected for Part D prescription drug plans, including higher premiums and out-of-pocket costs [1][4] - Beneficiaries must be vigilant regarding their coverage options and potential changes to their plans [2] Enrollment Period - The open enrollment period for Medicare runs from October 15 to December 7, allowing beneficiaries to modify their coverage, which will take effect on January 1 [3] Beneficiary Statistics - Out of 68.8 million Medicare beneficiaries, 54.8 million are enrolled in Part D prescription drug plans operated by private insurers, indicating a substantial portion of the population affected by upcoming changes [4] Cost Changes - In 2026, the annual out-of-pocket drug costs for seniors enrolled in Part D will be capped at $2,100, a provision from the 2022 Inflation Reduction Act [5] - However, this cap only applies to drugs covered by the plan, meaning beneficiaries will pay full price for non-covered medications [6] Deductibles and Premiums - Most Part D plans will have a deductible in 2026, with the maximum annual deductible increasing to $615 from $590 in 2025 [7]

Accessibility StatementSkip Navigation Investor contactLarry McGrath800-201-0938[email protected] SOURCE CVS Health WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+Newsrooms &Influencers 9k+Digital MediaOutlets 270k+JournalistsOpted In GET STARTED WOONSOCKET, R.I., Sept. 30, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, October 29, 2025, at 8:00 a.m. ET to discuss third quarter 2025 financial results. An audio webcast of the ev ...

Group 1 - CVS Health will hold a conference call on July 31, 2025, at 8:00 a.m. ET to discuss its second quarter 2025 financial results [1] - An audio webcast of the conference call will be available on the CVS Health Investor Relations website and archived for one year [1] Group 2 - As of March 31, 2025, CVS Health operates over 9,000 retail pharmacy locations and more than 1,000 walk-in and primary care medical clinics [2] - The company is a leading pharmacy benefits manager with approximately 88 million plan members and serves over 800,000 patients annually through its senior pharmacy care business [2] - CVS Health provides health insurance products and services to an estimated 37 million people, including Medicare Advantage offerings and a standalone Medicare Part D prescription drug plan [2] - The company's integrated model focuses on personalized, technology-driven services to enhance access to quality care, improve health outcomes, and reduce overall costs [2]

Leadership Updates - CVS Health announced the appointment of Brian Newman as executive vice president and chief financial officer designate, effective April 21, 2025, succeeding Tom Cowhey, who will transition to a strategic advisor role [5][9] - Amy Compton-Phillips, M.D., has been named executive vice president and chief medical officer, effective May 19, 2025, also reporting to CEO David Joyner [7][9] Financial Outlook - The company expects its financial results for the full year 2025 to meet or exceed previously issued guidance based on year-to-date results through February [2] Leadership Experience - Brian Newman previously served as executive vice president and chief financial officer of United Parcel Service, where he led the company through the COVID-19 pandemic [5][6] - Dr. Compton-Phillips was the chief physician executive of Press Ganey and has extensive experience in directing patient care programs and leading healthcare organizations [7][8] Company Overview - As of December 31, 2024, CVS Health operates over 9,000 retail pharmacy locations and more than 1,000 walk-in and primary care medical clinics, serving approximately 90 million pharmacy benefits plan members [9][10] - The company also provides health insurance products to over 36 million people, including Medicare Advantage offerings and a standalone Medicare Part D prescription drug plan [10]